在缺血性中风中种族-种族,年龄和心力衰竭
Chinwe Ibeh1, Randolph S Marshall1, Joshua Z Willey1
1Division of Stroke, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA.
概括
心力衰竭在黑人中风患者中更为常见,尤其是年轻人,并不能完全由危险因素解释. 这突显了急性缺血性中风幸存者心血管健康的种族差异.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 健康差异 在健康上的差异
背景情况:
- 种族种族差异对心血管疾病有很大影响.
- 心力衰竭 (HF) 是急性缺血性中风 (AIS) 的常见并发症,与患者的治疗结果较差有关.
研究的目的:
- 调查AIS患者中HF患病率的种族种族差异.
- 为了检查这些差异是否在年轻患者群体中更明显.
- 确定这些差异是否独立于传统的心血管风险因素.
主要方法:
- 从国家住院患者样本 (2016-2019) 中对AIS患者的分析.
- 患者被分为年轻 (<50岁),中年 (50-64岁) 和老年 (≥65岁) 的年龄组.
- 检查了年龄和种族-种族之间对HF并发症的相互作用,调整了血管风险因素,并分析了死亡率和住院时间.
主要成果:
- 在398,470名AIS患者中,有16.2%患有HF,黑人患者的患病率更高 (21.0%对16.4%).
- 种族-种族显著改变了年龄-HF关系 (P相互作用<0.001).
- 黑人患者在所有年龄段患上高血压的几率最高,最显著的是年轻人 (OR:2.08),独立于风险因素. 在HF患者中,黑人种族与较低的住院死亡率有关,但住院时间较长.
结论:
- 心力衰竭在患有急性缺血性中风的黑人患者中非常普遍,特别是在年轻人中.
- 即使考虑到心血管风险因素,这些差异仍然存在.
- 调查结果强调了在AIS后的高频率流行和结果中存在显著的种族种族差异.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
21.6K
相关概念视频
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:20Exercise and Cardiovascular Response
784
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
784
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:22Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363